SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-24-002533
Filing Date
2024-01-17
Accepted
2024-01-16 19:23:06
Documents
124

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 3537295
2 ex23-1.htm EX-23.1 2686
3 ex107.htm EX-FILING FEES 27941
4 logo_001.jpg GRAPHIC 11954
5 logo_002.jpg GRAPHIC 9058
  Complete submission text file 0001493152-24-002533.txt   13086952

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20230930.xsd EX-101.SCH 89750
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bfri-20230930_cal.xml EX-101.CAL 106005
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20230930_def.xml EX-101.DEF 408269
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20230930_lab.xml EX-101.LAB 621562
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20230930_pre.xml EX-101.PRE 551778
118 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 1992716
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-276535 | Film No.: 24536470
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)